09633 Overview

Strong Shipment Data: The Chinese essential consumer goods industry experienced robust shipment figures in January 2026, driven by higher-than-expected Spring Festival demand, although a slowdown is anticipated in March.

Market Competition: Goldman Sachs predicts intensified competition in the beverage sector as companies like TINGYI and EASTROC launch new promotions and products, particularly in green tea and sugar-free markets.

Sector Preferences: The broker favors the condiment and prepared food sectors, citing improved demand trends and supply cycles, while also highlighting dairy producers like MENGNIU DAIRY and YILI for their resilience against cost fluctuations.

Positive Outlook on Key Brands: Goldman Sachs maintains a positive stance on brands such as KWEICHOW MOUTAI and NONGFU SPRING, emphasizing their strong market positions and potential for growth despite short-term cost challenges.

Elon Musk's Wealth: Elon Musk has been named the world's richest person for the fifth time in six years, with his wealth increasing by 89% to RMB5.5 trillion, according to the Hurun Global Rich List 2026.

Top Rankings: Jeff Bezos ranks second with RMB2.1 trillion, while Larry Page and Sergey Brin are third and fifth, respectively, with wealth increases of 65% and 67%.

Chinese Entrepreneurs: In China, ByteDance founder Zhang Yiming is the richest with RMB550 billion, followed by Zhong Shanshan of NONGFU SPRING and Pony Ma of TENCENT.

CATL's Position: Robin Zeng, chairman of CATL, ranks fourth among Chinese entrepreneurs with a wealth increase of 46% to RMB380 billion, while Lei Jun and the Jack Ma family are tied for tenth with RMB230 billion.

Lunar New Year Consumption Performance: The Lunar New Year holiday showed strong demand in catering and tourism, prompting Daiwa to recommend stocks like GUMING and YUM CHINA that benefit from this trend.

Economic Reflation Signs: The report highlighted initial signs of reflation in the Chinese economy driven by service consumption, with rising prices and reduced promotions in various sectors.

Catering Sector Outlook: Daiwa remains optimistic about GUMING and YUM CHINA, suggesting that a broader recovery in catering could enhance alcohol consumption at venues, while also favoring NONGFU SPRING and TINGYI due to domestic tourism.

Caution on MIXUE GROUP: Despite the positive outlook for many stocks, Daiwa expressed caution regarding MIXUE GROUP due to uncertain profit growth visibility, maintaining a Neutral rating.

Goldman Sachs Forecast: Goldman Sachs predicts NONGFU SPRING will achieve RMB51.1 billion in sales and RMB15.2 billion in net profit for 2025, reflecting year-on-year growth of 19% and 26%, respectively.

Revised Projections: The broker has raised its revenue and net profit forecasts for 2025-27 by 1-2% and approximately 2%, with a target price increase from HKD58.6 to HKD60 and a reiterated Buy rating.

Market Recovery: NONGFU SPRING reported a rapid recovery in market share for packaged water and strong customer retention for ready-to-drink tea beverages in 4Q25, with expected revenue growth of 25% YoY for these segments.

Financial Projections: Daiwa forecasts a 23% YoY increase in revenue and a 28% YoY increase in net profit for NONGFU SPRING in 2H25, leading to a 2% upward revision in the 2025 EPS forecast.

Future Focus: Looking ahead to 2026, NONGFU SPRING plans to continue prioritizing its packaged water and ready-to-drink tea businesses to sustain growth.

Broker Rating Update: Daiwa maintained a "Buy" rating for NONGFU SPRING while raising its 12-month target price from $59 to $58, with a target PE ratio of 33x.

US Stock Market Performance: US stocks fell 398 points (0.8%) following JPMorgan's earnings report, while chip stocks saw increased interest.

Hong Kong Market Opening: The Hong Kong bourse opened higher, with the HSI up 123 points (0.5%) and notable gains in tech stocks like BABA-W and TENCENT.

Inflation Rate in China: China's inflation rate for December was reported at 0.8%, slightly above the previous 0.7% but below the forecast of 0.9%.

Pharmaceutical Sector Activity: Several pharmaceutical stocks, including HANSOH PHARMA and BEONE MEDICINES, opened higher, while PHARMARON anticipated a decrease in full-year profit but still saw a slight increase in stock price.